Savitz Ryan - Insider Non-Derivative Transactions at Dianthus Therapeutics, Inc. /DE/ (DNTH) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 4, 2025, Savitz Ryan's relationship to Dianthus Therapeutics, Inc. /DE/ (DNTH) is Officer (CFO & CBO), and currently has 20,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other DNTH insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Savitz Ryan - Insider Non-Derivative Transactions of DNTH Common Stock

Savitz Ryan - Insider Non-Derivative Transactions at DNTH

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 5, 2025	Sell -- (Common Stock)	20000	45.18	0
Dec 5, 2025	M -- (Common Stock)	20000	8.44	20000
Sep 10, 2025	Sell -- (Common Stock)	20000	35	0
Sep 10, 2025	M -- (Common Stock)	20000	8.44	20000